Imrecoxib is a selective cyclooxygenase-2 (COX-2) inhibitor classified as a nonsteroidal anti-inflammatory drug (NSAID), which is primarily indicated for the relief of pain, swelling, and stiffness associated… Read more











































Imrecoxib is a selective cyclooxygenase-2 (COX-2) inhibitor classified as a nonsteroidal anti-inflammatory drug (NSAID), which is primarily indicated for the relief of pain, swelling, and stiffness associated with osteoarthritis. Pharmaceutical laboratories require access to precise reference standards for this compound to maintain rigorous quality control protocols. This collection provides the necessary materials to support analytical testing, including impurity profiling to detect process-related byproducts and degradants. By incorporating metabolites and stable isotope labelled compounds into their workflows, researchers can enhance the accuracy of method validation and bioanalytical studies. These essential tools are critical for ensuring regulatory compliance and consistency throughout the drug development process, allowing chemists to accurately identify and quantify the active pharmaceutical ingredient alongside its related impurities and potential degradation pathways.